Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac versus placebo for symptomatic knee osteoarthritis pain
2024-510757-95-01Phase 4Completed
- Sponsor
- Nordic Bioscience Clinical Development
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in knee osteoarthritis (OA) comparing Diclofenac with Placebo (2 arms). Primary endpoint: Change in KOOS pain assessed with PRMS. Started Aug 2024; status: completed.
02
Drugs
diclofenac
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2024-510757-95-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-510757-95-01.